Oral phosphate binders
- 1 May 2009
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 75 (9), 906-914
- https://doi.org/10.1038/ki.2009.60
Abstract
No abstract availableThis publication has 85 references indexed in Scilit:
- Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of TreatmentNephron Clinical Practice, 2008
- Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burdenNephrology Dialysis Transplantation, 2008
- The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKDJournal of the American Society of Nephrology, 2008
- A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the Dialysis Clinical Outcomes Revisited (DCOR) Randomized Trial Using Claims DataAmerican Journal of Kidney Diseases, 2008
- Effects of Sevelamer and Calcium-Based Phosphate Binders on Mortality in Hemodialysis Patients: Results of a Randomized Clinical TrialJournal of Renal Nutrition, 2008
- Phosphate Is a Uremic ToxinJournal of Renal Nutrition, 2008
- Magnesium Carbonate Is an Effective Phosphate Binder for Chronic Hemodialysis Patients: A Pilot StudyJournal of Renal Nutrition, 2007
- Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patientsKidney International, 2007
- Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patientsKidney International, 2007
- Hypocalcemia, Morbidity, and Mortality in End-Stage Renal DiseaseAmerican Journal of Nephrology, 1996